Transcription of the article from Biomedical Materials, published on June 20, 2020:
Today, scientists are focusing on the development of personalized and tissue-specific bio-inks that can be used in 3D bioprinting technologies.
Platelet-rich plasma is a person-specific source used as a therapeutic complement for the treatment of cartilage injuries because it provides a cocktail of growth factors necessary for wound healing and tissue regeneration.
However, clinical PRP treatments are not satisfactory and need improvement, especially in terms of maintaining bioactivity.